• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Galen Institute

  • Home
  • About Us
    • Mission and History
    • Grace-Marie Turner bio
    • Who was Galen?
  • Activities
    • Core Activities
    • Commentary and Oped Tutorial
    • Our Book
    • Galen Guides
  • Contact Us
  • Major Papers
  • Broadcast Interviews
  • Health Policy Consensus Group

Response to Roger Lowenstein article in The New York Times Magazine

POSTED BY Galen Institute on March 14, 2005.

Reporter Roger Lowenstein’s March 13 article in the Magazine(“The Quality Cure?”) misstates the approach of “right-wingers,” as he describes those who believe in a market approach to health reform. He writes that “If people paid for their own angioplasties, so the theory goes, they would have fewer of them. This is the theory behind Bush’s health savings accounts…”

 

This is inaccurate. HSAs are in fact designed to provide consumers more control over routine health expenditures, and the accounts must be coupled with high-deductible health insurance, which certainly would kick-in if a patient were to require an angioplasty. Lowenstein gives a short and inaccurate portrayal of the ideas of those who believe in new incentive programs to engage consumers in health spending decisions while devoting several thousand words to the perspective of those from the other side. A bit more balance certainly seems in order.

 

Grace-Marie Turner

President

Galen Institute

 

 

 

Filed Under: Uncategorized

Response to Roger Lowenstein article in The New York Times Magazine

POSTED BY Galen Institute on March 14, 2005.

Reporter Roger Lowenstein’s March 13 article in the Magazine(“The Quality Cure?”) misstates the approach of “right-wingers,” as he describes those who believe in a market approach to health reform. He writes that “If people paid for their own angioplasties, so the theory goes, they would have fewer of them. This is the theory behind Bush’s health savings accounts…”

 

This is inaccurate. HSAs are in fact designed to provide consumers more control over routine health expenditures, and the accounts must be coupled with high-deductible health insurance, which certainly would kick-in if a patient were to require an angioplasty. Lowenstein gives a short and inaccurate portrayal of the ideas of those who believe in new incentive programs to engage consumers in health spending decisions while devoting several thousand words to the perspective of those from the other side. A bit more balance certainly seems in order.

 

Grace-Marie Turner

President

Galen Institute

 

 

 

Filed Under: Uncategorized

Primary Sidebar

Our Annual Report

Health Care Choices 20/20:

A Vision for the Future

SEARCH

Categories

  • Brian Blase
  • Consumer-Directed Care
  • Doug Badger
  • Grace-Marie Turner
  • Health Insurance
  • Health Policy Consensus Group
  • Health Savings Accounts
  • Innovation
  • Medicaid
  • Medicare
  • Newsletter
  • ObamaCare
  • Prescription Drugs
  • Published
    • Forbes
    • Fox Business
    • Health Affairs
    • LA Times
    • National Review
    • New York Post
    • RealClearHealth
    • Sun Sentinel
    • The Daily Signal
    • The Heritage Foundation
    • The Hill
    • The New York Times
    • The Wall Street Journal
    • The Washington Times
  • Reform Initiatives
  • State Issues
  • Uncategorized

LATEST NEWSLETTER ISSUES

SUBSCRIBE

Social Media

Like Us On Facebook

Twitter: @galeninstitute

 

Copyright Galen Institute at Donors. © 2023; · Log in